OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interplay between Non-Coding RNAs and NRF2 in Different Cancers: Spotlight on MicroRNAs and Long Non-Coding RNAs
İlhan Yaylım, Ammad Ahmad Farooqı, Pelin Telkoparan‐Akillilar, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 28-34
Open Access | Times Cited: 7
İlhan Yaylım, Ammad Ahmad Farooqı, Pelin Telkoparan‐Akillilar, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 28-34
Open Access | Times Cited: 7
Showing 7 citing articles:
Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes
Pasquale Mone, Angela Lombardi, Urna Kansakar, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 116-122
Open Access | Times Cited: 68
Pasquale Mone, Angela Lombardi, Urna Kansakar, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 116-122
Open Access | Times Cited: 68
Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment
Xinyi Yang, Yingchao Liu, Jie Cao, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Xinyi Yang, Yingchao Liu, Jie Cao, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression
Zuxiong Zhang, Qianshun Chen, Chen Huang, et al.
Molecular Carcinogenesis (2022) Vol. 61, Iss. 12, pp. 1161-1176
Closed Access | Times Cited: 13
Zuxiong Zhang, Qianshun Chen, Chen Huang, et al.
Molecular Carcinogenesis (2022) Vol. 61, Iss. 12, pp. 1161-1176
Closed Access | Times Cited: 13
Moving theJournal of Pharmacology and Experimental TherapeuticsForward to Address the Needs of Our Authors and Editors—Editorial
Beverley Greenwood-Van Meerveld, Roberto Levi, Eric R. Gross, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 388, Iss. 1, pp. 1-5
Open Access | Times Cited: 1
Beverley Greenwood-Van Meerveld, Roberto Levi, Eric R. Gross, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 388, Iss. 1, pp. 1-5
Open Access | Times Cited: 1
MitoQ Alleviated PM2.5 Induced Pulmonary Epithelial Cells Injury by Inhibiting Mitochondrial-Mediated Apoptosis
Aibin Weng, Meng-Meng Deng, Xiaodan Liu, et al.
Iranian Journal of Public Health (2024)
Open Access | Times Cited: 1
Aibin Weng, Meng-Meng Deng, Xiaodan Liu, et al.
Iranian Journal of Public Health (2024)
Open Access | Times Cited: 1
Non-Coding RNAs in Clinical Practice: From Biomarkers to Therapeutic Tools
Gaetano Santulli
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 225-226
Open Access | Times Cited: 3
Gaetano Santulli
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 225-226
Open Access | Times Cited: 3
Multifunctional role of Nobiletin in cancer chemoprevention
Durr-e-shahwar Malik, Rükset Attar, Ülkü Özbey, et al.
Cellular and Molecular Biology (2022) Vol. 68, Iss. 7, pp. 200-207
Open Access | Times Cited: 2
Durr-e-shahwar Malik, Rükset Attar, Ülkü Özbey, et al.
Cellular and Molecular Biology (2022) Vol. 68, Iss. 7, pp. 200-207
Open Access | Times Cited: 2
